abstract |
It is also possible to use dihydropyridine derivatives with fused carbon or heterocyclic rings of formula I or tautomeric forms of formulas II 'or II' 'for the manufacture of pharmaceutical compositions with a neuroprotective effect, in particular for the protection of brain tissues. . \ |